Magnasense AB (FRA:52Q) Debt-to-Asset : 1.35 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Magnasense AB Debt-to-Asset?

Magnasense AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €0.47 Mil. Magnasense AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €3.36 Mil. Magnasense AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was €2.84 Mil. Magnasense AB's debt to asset for the quarter that ended in Dec. 2024 was 1.35.

Magnasense AB Debt-to-Asset Historical Data

The historical data trend for Magnasense AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magnasense AB Debt-to-Asset Chart

Magnasense AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Asset

Get a 7-Day Free Trial

0.02

0.11

0.62

1.35

Magnasense AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial															0.62	0.74	0.75	0.78	1.35

Competitive Comparison of Magnasense AB's Debt-to-Asset

For the Medical Devices subindustry, Magnasense AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Magnasense AB's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Magnasense AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Magnasense AB's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Magnasense AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Magnasense AB's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.47	+	3.356)	/	2.835
	=	1.35

Magnasense AB's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.47	+	3.356)	/	2.835
	=	1.35

Magnasense AB (FRA:52Q) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Magnasense AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Magnasense AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Magnasense AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Magnasense AB (FRA:52Q) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

MAGNA:Sweden

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.aegirbio.com

AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.

Magnasense AB Headlines

No Headlines